Ken Griffin
LRMR icon

Ken Griffin’s Larimar Therapeutics LRMR Stock Holding History

Ken Griffin’s Portfolio LRMR Stock Details LRMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$220K Buy
48,800
+31,300
+179% +$125K ﹤0.01% 11224
2025
Q4 		$66.7K Sell
17,500
-82,100
-82% -$319K ﹤0.01% 11895
2025
Q3 		$322K Buy
99,600
+39,600
+66% +$148K ﹤0.01% 10197
2025
Q2 		$173K Buy
60,000
+44,800
+295% +$104K ﹤0.01% 10818
2025
Q1 		$32.7K Sell
15,200
-15,600
-51% -$49.3K ﹤0.01% 12737
2024
Q4 		$119K Buy
30,800
+1,400
+5% +$9.24K ﹤0.01% 11204
2024
Q3 		$193K Buy
29,400
+27,100
+1,178% +$218K ﹤0.01% 10210
2024
Q2 		$16.7K Sell
2,300
-15,900
-87% -$122K ﹤0.01% 12776
2024
Q1 		$138K Buy
18,200
+18,000
+9,000% +$140K ﹤0.01% 10891
2023
Q4 		$910 Sell
200
-500
-71% -$1.69K ﹤0.01% 13918
2023
Q3 		$2.77K Sell
700
-700
-50% -$2.65K ﹤0.01% 13673
2023
Q2 		$4.38K Buy
1,400
+700
+100% +$2.86K ﹤0.01% 13601
2023
Q1 		$3.17K Buy
+700
New +$3.66K ﹤0.01% 14065
2016
Q3 		– Sell
-867
Closed -$62K – 7520
2016
Q2 		$62K Buy
+867
New +$68.5K ﹤0.01% 6355
2016
Q1 		– Sell
-192
Closed -$14K – 7444
2015
Q4 		$14K Sell
192
-75
-28% -$12K ﹤0.01% 8142
2015
Q3 		$102K Buy
+267
New +$120K ﹤0.01% 6941

Other funds holding LRMR

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Ken Griffin's LRMR Position: Q1 2026 in Review

Ken Griffin reduced its Larimar Therapeutics (LRMR) stake by 62% in Q1 2026, selling an estimated $3.39M and leaving 519,132 shares worth $2.34M. The position accounts for ﹤0.01% of the portfolio, ranked #5758.

Ken Griffin first reported a position in LRMR in Q2 2014 and has held it in 31 quarters since. The position peaked at $12.2M in Q3 2018. 162 funds tracked by Wall St. Rank hold LRMR as of Q1 2026.

  • Ken Griffin held 519,132 shares of Larimar Therapeutics worth $2.34M as of Q1 2026.
  • Ken Griffin sold 847,618 Larimar Therapeutics shares in Q1 2026, an estimated $3.39M.
  • Larimar Therapeutics made up ﹤0.01% of Ken Griffin's portfolio in Q1 2026, its #5758 holding.
  • Ken Griffin first reported a position in Larimar Therapeutics in Q2 2014 and has held it in 31 quarters since.
  • Ken Griffin's Larimar Therapeutics position peaked at $12.2M in Q3 2018.
  • 162 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.